Notably, while CXCL14 upregulation has been documented in IPF-derived lung fibroblasts, its role in immune modulation and potential as a prognostic biomarker remain systematically uncharacterized. The gene discussed is CXCL14; the disease is idiopathic pulmonary fibrosis.